Related Experiment Video
Updated: Apr 26, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
25.1K
Controlling Parkinson's disease with adaptive deep brain stimulation.
Simon Little1, Alek Pogosyan1, Spencer Neal2
1Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford.
Journal of Visualized Experiments : Jove
|August 1, 2014
Summary
Adaptive deep brain stimulation (aDBS) optimizes Parkinson's treatment by adjusting stimulation in real-time. This approach shows promise for improved motor function and reduced power consumption compared to conventional methods.
Area of Science:
- Neuroscience
- Biomedical Engineering
Background:
- Parkinson's disease treatment can be improved by real-time adaptive deep brain stimulation (aDBS).
- Current aDBS systems optimize stimulation based on fluctuating patient states.
Purpose of the Study:
- To evaluate the efficacy of a newly developed aDBS system in Parkinson's disease patients.
- To assess real-time optimization of subthalamic nucleus stimulation.
Main Methods:
- aDBS electrodes implanted in the subthalamic nucleus were used for recording and stimulation.
- Local field potentials were filtered, and beta amplitude was monitored online.
- Stimulation was triggered by elevated beta amplitude thresholds and adjusted dynamically.
Main Results:
- The aDBS system demonstrated reduced power consumption compared to conventional deep brain stimulation.
- Clinical efficacy was assessed via video evaluation of motor function using UPDRS scores.
- Improved clinical scores were observed with aDBS.
Conclusions:
- Adaptive deep brain stimulation offers a promising approach for Parkinson's disease management.
- The developed aDBS system shows potential for chronic implantation and further trials in Parkinsonism.
Related Concept Videos
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:24Parkinson Disease l: Introduction
18
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
18